| |
ASM/ICAAC: Potent Activity of Bictegravir (BIC; GS-9883), a Novel Unboosted HIV-1 Integrase Strand Transfer Inhibitor (INSTI), Against Patient Isolates
with INSTI-Resistance
|
| |
| |
Reported by Jules Levin
ASM/ICAAC 2016 June 16-20 Boston, MA
Kirsten White, Tomas Cihlar and Michael D. Miller
Gilead Sciences, Foster City, CA
|
|
| |
| |
|
|
|
